Skip to content

Efficacy of Lactulose versus combination of Senna and Ispaghula husk in Pre-Dialysis Chronic kidney disease patient with Constipations: A Randomized Controlled Trial

Efficacy of Lactulose versus combination of Senna and Ispaghula husk in Pre-Dialysis Chronic kidney disease patient with Constipations: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20200818006
Enrollment
Unknown
Registered
2020-08-18
Start date
2017-02-20
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pre&#45

Interventions

lactulose or daily for 14 days. After a 7&#45
day washout period&#44
the patients were switched to the other substance for another 14 days. ,senna and ispaghula husk daily for 14 days. After a 7&#45
the patients were switched to the other substance for another 14 days.
Active Comparator Drug,Active Comparator Drug
lactulose and,senna and ispaghula

Sponsors

None
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: CKD stage 4 and 5 with non-dialysis, aged > 18 years, who were diagnosed constipation by ROME IV criteria

Exclusion criteria

Exclusion criteria: history of abdominal surgery, gut obstruction, pregnancy, end stage renal disease who on dialysis, history of lactulose, senna, fiber allergy, and history of bulimia and anorexia. Discontinuation criteria included unwillingness to continue study, intolerable side-effects or allergy.

Design outcomes

Primary

MeasureTime frame
compare efficacy of lactulose and combination of senna and ispaghula husk for treat constipations in 14 days complete spontaneous bowel movement (CSBM) per week which complete spontaneous was assessed using st

Secondary

MeasureTime frame
change of stool appearance 14 days Bristol stool form scale (BSFS).

Countries

Thailand

Contacts

Public ContactNaowanit Nata

Division of Nephrology, Department of Medicine, Phramongkutklao Hospital and College of Medicine

Naowanitnata2017@gmail.com662-6444676

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026